Recombinant Human CDKN2A/p16INK4a protein
Recombinant Human CDKN2A/p16INK4a protein
Be the first to review this product! Submit a review
|
(2 Publications)
Recombinant Human CDKN2A/p16INK4a protein is a Human Full Length protein, in the 1 to 156 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE.
查看别名
CDKN2, MTS1, CDKN2A, Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1, p16-INK4a, CDK4I, MTS-1, p16-INK4, p16INK4A
- sELISA
Unknown
Sandwich ELISA - Recombinant Human CDKN2A/p16INK4a protein (AB84075)
Standard Curve for CDKN2A/p16INK4a (Analyte : CDKN2A/p16INK4a protein (Human) (ab84075)); dilution range 1pg/ml to 1μg/ml using Capture Antibody Mouse monoclonal [DCS50.1] to CDKN2A/p16INK4a (ab16123) at 1μg/ml and Detector Antibody Rabbit polyclonal to CDKN2A/p16INK4a (ab7962) at 0.5μg/ml.
反应性数据
产品详情
序列信息
性能和储存信息
运输条件
推荐的长期储存条件
储存信息
特殊说明
形式
Lyophilized
附加说明
Purity is greater than 95% by SDS-PAGE gel and HPLC analyses.
常规信息
功能
The protein expressed by the gene CDKN2A acts as a negative regulator of normal cell proliferation by strongly interacting with CDK4 and CDK6. This interaction inhibits the ability of CDK4 and CDK6 to interact with cyclins D and to phosphorylate the retinoblastoma protein. This supplementary information is collated from multiple sources and compiled automatically.
序列相似性
Belongs to the CDKN2 cyclin-dependent kinase inhibitor family.
翻译后修饰
Phosphorylation seems to increase interaction with CDK4.
亚细胞定位
Nucleus
靶点信息
文献 (2)
Recent publications for all applications. Explore the full list and refine your search
Asian Pacific journal of cancer prevention : APJCP 16:5115-8 PubMed26163652
2015
Applications
Unspecified application
Species
Unspecified reactive species
Asian Pacific journal of cancer prevention : APJCP 15:9375-8 PubMed25422227
2014
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com